OEM 99% CAS 15307-81-0 Diclofenac Potassium Powder Diclofenac Potassium Tablet API Diclofenac Potassium

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-Sung Diclofenac potassium
• Product Name: Diclofenac Potassium
• Name: Diclofenac Potassium Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 15307-81-0
• Mf: C14h10cl2kno2
• MW: 334.237
• Boiling Point: 412 °c at 760 Mmhg
• Melting Point: 156-158 Deg C
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

OEM 99% CAS 15307-81-0 Diclofenac potassium powder Diclofenac Potassium Tablet API Diclofenac potassium

Product Description

Product Details

Product name	Diclofenac potassium
Appearance	White powder
CAS NO.	15307-81-0
MF	C14H10Cl2KNO2
MW	334.237

Dichlofenac potassium is the potassium salt of dichlofenac. It is a nonsteroidal anti-inflammatory agent that can be used to reduce inflammation and as an analgesic to reduce pain in certain conditions. It can also used to treat dysmenorrhea. It can treat inflammatory disorders such as musculoskeletal complaints, dental pain, arthritis, actinic keratosis, joint pain, acute pain and chronic pain caused by certain kinds of cancers. Traditional opinion proposes that diclofenac exerts its action via inhibition of prostaglandin synthesis by inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) with relative equipotency. However, recent studies have shown that the pharmacologic activity of diclofenac goes beyond COX inhibition, and includes multimodal and, in some instances, novel mechanisms of action (MOA). For example, research suggests diclofenac can inhibit the thromboxane-prostanoid receptor, affect arachidonic acid release and uptake, inhibit lipoxygenase enzymes, and activate the nitric oxide-cGMP antinociceptive pathway. Other novel MOAs may include the inhibition of substrate P, inhibition of peroxisme prolferator ativated receptor gamma (PPARγ), blockage of acid-sensing ion channels, alteration of interleukin-6 production, and inhibition of N-methyl-D-aspartate (NMDA) receptor hyperalgesia.

Application&Function

Cataflam (diclofenac potassium) is used to treat pain or inflammation caused by arthritis or ankylosing spondylitis. It is a nonsteroidal anti-inflammatory drug (NSAID). This medication is available in generic form. Common side effects include upset stomach, nausea, heartburn, diarrhea, constipation, gas, headache, drowsiness, and dizziness.

Specification